High-Dose Diflucan May Cause Birth Defects: FDA

Law360, New York (August 3, 2011, 6:32 PM EDT) -- The U.S. Food and Drug Administration warned Wednesday that high doses of Pfizer Inc.'s antifungal drug Diflucan, used to treat yeast infections and fungal meningitis, may cause birth defects if taken in the first trimester of pregnancy.

The FDA changed the pregnancy category for fluconazole, Diflucan's active ingredient, from C to D, meaning there is positive evidence of fetal risk from taking the drug but that it still may be beneficial in serious or life-threatening situations.

Several case studies showed a possible correlation between long-term use...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.